David Pyott Leaves Edwards’ Board Amid Allergan Takeover Challenges
This article was originally published in The Gray Sheet
Executive Summary
Allergan CEO David Pyott’s announcement to leave Edward Lifescience’s board of directors comes on the heels of news that Allergan’s battle to block a takeover by Valeant has hit new challenges.